Glycolic Acid → HCID 59464215, compound
Reaction equation
CCN=C=NCCCN(C)C.[F:12][C:13]1[CH:18]=[CH:17][CH:16]=[CH:15][C:14]=1[NH:19][C:20]1[O:24][C:23]([C:25]([NH:27][C:28]2[CH:29]=[N:30][C:31]([N:34]3[CH2:39][CH2:38][NH:37][CH2:36][CH2:35]3)=[CH:32][CH:33]=2)=[O:26])=[N:22][N:21]=1.[C:40](O)(=[O:43])[CH2:41][OH:42].C1C=CC2N(O)N=NC=2C=1>CN(C=O)C.O>[F:12][C:13]1[CH:18]=[CH:17][CH:16]=[CH:15][C:14]=1[NH:19][C:20]1[O:24][C:23]([C:25]([NH:27][C:28]2[CH:29]=[N:30][C:31]([N:34]3[CH2:39][CH2:38][N:37]([C:41](=[O:42])[CH2:40][OH:43])[CH2:36][CH2:35]3)=[CH:32][CH:33]=2)=[O:26])=[N:22][N:21]=1Participants
7
Procedure
EDAC (60 mg, 0.31 mmol) was added to a stirred mixture of 5-[(2-fluorophenyl)amino]-N-(6-piperazin-1-ylpyridin-3-yl)-1,3,4-oxadiazole-2-carboxamide (Intermediate 41, 100 mg, 0.26 mmol), glycolic acid (20 mg (0.26 mmol) and HOBt (42 mg, 0.31 mmol) in 3 mL of DMF and stirring was continued for 16 h. Water (10 mL) was added and the resultant precipitate was collected by filtration, washed with water then ether and dried in vacuo to give the title compound (75 mg, 65%) as a solid; 1H NMR δ 10.94 (1H, s), 10.70 (1H, s), 8.50 (1H, s), 8.05 (1H, t), 7.90 (1H, d), 7.35-7.20 (2H, m), 7.20-7.10 (1H, m), 6.90 (1H, d), 4.60 (1H, t), 4.10 (2H, d), 3.60-3.4 (8H, m); MS m/e MH+ 442.
Workup
- filtrationthe resultant precipitate was collected by filtration
- washwashed with water
- dry with materialether and dried in vacuo
Sources & evidence
- ORD record
- ord-b8e3d44b10cf425293a481ce7f459fde
- Source dataset
- uspto-grants-2010_09
- Patent number
- US07795283B2
Reaction notes
Loading…